Literature DB >> 25208440

Implementation and evaluation of a multicomponent quality improvement intervention to improve efficiency of hepatitis C screening and diagnosis.

Amy A Hirsch, Renée H Lawrence, Elizabeth Kern, Yngve Falck-Ytter, Davis T Shumaker, Brook Watts.   

Abstract

BACKGROUND: Given recent advances in hepatitis C virus (HCV) treatment, health systems must ensure that patients with a positive HCV antibody receive timely determination of their HCV status through viral testing. At the Louis Stokes Cleveland Department of Veterans Affairs Medical Center, viral testing was completed within six months of the first instance of a positive HCV antibody test for only 45% of patients. Beginning in 2008, three sequential improvements were implemented to close this care gap.
METHODS: The three sequential improvements phases were as follows: (1) improving patient-centeredness of screening process in ambulatory patients, (2) local implementation of the Department of Veterans Affairs national HCV reflex testing policy, and (3) local evaluation of the efficiency and effectiveness of local implementation of reflex testing.
RESULTS: From 2005 through 2013, 40 to 150 unique patients/quarter required viral testing following a positive antibody test. The firsts and second-phase improvements resulted in a 68% and 96% completion rate for timely viral testing during respective improvement phases. In the third improvement phase, remaining process problems related to the reflex testing process were identified using a locally developed electronic HCV population management application, resulting in a sustained rate of 100% completion of timely viral testing. Interrupted time series analysis revealed that the implementation of HCV reflex testing had the largest impact on the ability to complete timely viral testing.
CONCLUSIONS: A continuous quality improvement approach, supported by an HCV population management application, achieved the complete closure of an important HCV care gap. Reflex testing should be initiated at facilities that have yet to adopt this approach.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25208440     DOI: 10.1016/s1553-7250(14)40046-1

Source DB:  PubMed          Journal:  Jt Comm J Qual Patient Saf        ISSN: 1553-7250


  8 in total

1.  Hepatitis C Virus (HCV) Care Continuum Outcomes and HCV Community Viral Loads Among Patients in an Opioid Treatment Program.

Authors:  Ashly E Jordan; Charles M Cleland; Bruce R Schackman; Katarzyna Wyka; David C Perlman; Denis Nash
Journal:  J Infect Dis       Date:  2020-09-02       Impact factor: 5.226

2.  Survey of programmatic experiences and challenges in delivery of hepatitis B and C testing in low- and middle-income countries.

Authors:  Azumi Ishizaki; Julie Bouscaillou; Niklas Luhmann; Stephanie Liu; Raissa Chua; Nick Walsh; Sarah Hess; Elena Ivanova; Teri Roberts; Philippa Easterbrook
Journal:  BMC Infect Dis       Date:  2017-11-01       Impact factor: 3.090

3.  Beyond interferon side effects: What residual barriers exist to DAA hepatitis C treatment for people who inject drugs?

Authors:  Annie Madden; Max Hopwood; Joanne Neale; Carla Treloar
Journal:  PLoS One       Date:  2018-11-30       Impact factor: 3.240

4.  Scaling up the in-hospital hepatitis C virus care cascade in Taiwan.

Authors:  Chung-Feng Huang; Pey-Fang Wu; Ming-Lun Yeh; Ching-I Huang; Po-Cheng Liang; Cheng-Ting Hsu; Po-Yao Hsu; Hung-Yin Liu; Ying-Chou Huang; Zu-Yau Lin; Shinn-Cherng Chen; Jee-Fu Huang; Chia-Yen Dai; Wan-Long Chuang; Ming-Lung Yu
Journal:  Clin Mol Hepatol       Date:  2020-12-03

5.  Hepatitis C Screening in People With Human Immunodeficiency Virus: Lessons Learned From Syphilis Screening.

Authors:  Alysse G Wurcel; Daniel D Chen; Rosemary E Fitzpatrick; Paula E Grasberger; Caleb H Kirshner; Jordan E Anderson; Kenneth K H Chui; Tamsin A Knox
Journal:  Open Forum Infect Dis       Date:  2016-02-12       Impact factor: 3.835

6.  Health Disparities in Hepatitis C Screening and Linkage to Care at an Integrated Health System in Southeast Michigan.

Authors:  Kassem Bourgi; Indira Brar; Kimberly Baker-Genaw
Journal:  PLoS One       Date:  2016-08-15       Impact factor: 3.240

7.  Persistent Challenges in the Hepatitis C Virus Care Continuum for Patients in a Central Texas Public Health System.

Authors:  Shane W Reader; Hyun-Seok Kim; Hashem B El-Serag; Aaron P Thrift
Journal:  Open Forum Infect Dis       Date:  2020-08-07       Impact factor: 3.835

8.  Australia could miss the WHO hepatitis C virus elimination targets due to declining treatment uptake and ongoing burden of advanced liver disease complications.

Authors:  Jisoo A Kwon; Gregory J Dore; Behzad Hajarizadeh; Maryam Alavi; Heather Valerio; Jason Grebely; Rebecca Guy; Richard T Gray
Journal:  PLoS One       Date:  2021-09-16       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.